Keyphrases
Positron Emission Tomography-computed Tomography (PET-CT)
100%
Primary Neoplasms
100%
Primary Prostate Cancer
100%
18F-fluciclovine PET
100%
Second Neoplasm
44%
Renal Cell Carcinoma
33%
SUVmax
33%
Incidental
33%
Second Primary Neoplasms
33%
Prostate Cancer
22%
Malignancy
22%
Cutaneous Squamous Cell Carcinoma (cSCC)
22%
Clear Cell Renal Cell Carcinoma (ccRCC)
11%
Lung Squamous Cell Carcinoma
11%
Ultrasound Findings
11%
Detection Rate
11%
Multiple Myeloma
11%
Patient Demographics
11%
Demographic Data
11%
CT Studies
11%
Radiotracer
11%
Esophageal Carcinoma
11%
Meningioma
11%
Primary Cancer
11%
Maximum SUV
11%
Radiological Assessment
11%
Tumor Imaging
11%
Lung Carcinoma
11%
Low Uptake
11%
Patients with Prostate Cancer
11%
Imaging Report
11%
Chondrosarcoma
11%
Initial Staging
11%
Squamous Carcinoma Cells
11%
Tissue Diagnosis
11%
Urothelial Carcinoma
11%
Imaging Capability
11%
MRI Findings
11%
Esophageal Squamous Cell Carcinoma
11%
Second Malignancy
11%
Carcinoma Squamous Cell
11%
Primary Lung Carcinoma
11%
Solitary Pulmonary Nodule
11%
Medicine and Dentistry
Neoplasm
100%
Positron Emission Tomography-Computed Tomography
100%
Prostate Cancer
100%
Fluciclovine F 18
100%
Clear Cell Renal Cell Carcinoma
44%
Second Cancer
44%
Cancer
22%
Magnetic Resonance Imaging
22%
Lung Carcinoma
22%
Skin Carcinoma
22%
Primary Tumor
11%
Squamous Cell Carcinoma
11%
Esophagus
11%
Clinical Study
11%
Radioactive Tracer
11%
Recurrent Disease
11%
Multiple Myeloma
11%
Esophagus Carcinoma
11%
Meningioma
11%
Radiologic Studies
11%
Lung Nodule
11%
Tumor Imaging
11%
Transitional Cell Carcinoma
11%
Chondrosarcoma
11%
Incidental Finding
11%
Squamous Cell Carcinoma Cell
11%